Viewing nowTelmisartan 40 mg Tablets (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Pamgen Science Co., Ltd.

MFDS item code 201805064 · Approved 2018.12.13 · Insurance code 670104330
Prevention of myocardial infarction and stroke due to essential hypertension and reduction of cardiovascular disease risk
This medication is used to effectively lower blood pressure in patients with essential hypertension and reduce the risk of cardiovascular diseases. It is particularly beneficial for patients over 55 years old with a history of coronary artery disease, peripheral artery disease, strokes, and transient ischemic attacks, or those with high-risk diabetes resulting in organ damage. It helps reduce the risk of myocardial infarction, stroke, and death due to cardiovascular diseases, thus significantly protecting patients’ cardiovascular health and lowering risks. Therefore, this drug is highly useful in managing hypertension and cardiovascular disease risks.
1. Essential Hypertension As Telmisartan, take 40 mg once daily with water, with or without food. Depending on the patient, 20 mg once daily may be effective. If necessary, the dosage can be increased to 80 mg once daily, with the maximum antihypertensive effect typically occurring 4 to 8 weeks after dosage increase. 2. Reducing Risk of Cardiovascular Disease As this drug, it is recommended to take 80 mg once daily with water, with or without food. The risk reduction effect on the morbidity and mortality of cardiovascular disease at dosages below 80 mg is not known. If initiating treatment with this drug for cardiovascular disease risk reduction, it is recommended to monitor blood pressure for appropriate adjustment of antihypertensive therapy. ○ For Patients with Liver Impairment Care should be taken in mild to moderate liver impairment, and the dose should not exceed 40 mg once daily.
This drug can cause serious harm to the fetus and newborn during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. This drug should not be administered to individuals who are allergic to it, are pregnant or breastfeeding, suffer from severe liver impairment or biliary obstruction, have hereditary angioedema, or have certain kidney diseases. Caution should be exercised when administering this drug to elderly patients or those with high potassium levels, liver impairment, valvular heart disease, ischemic heart disease, gastrointestinal diseases, or renal vascular hypertension. Various adverse reactions, including infection, hypoglycemia, low blood pressure, liver function abnormalities, kidney function deterioration, angioedema, myalgia, etc., may occur during treatment, hence patients should be closely monitored for symptoms. In particular, if blood pressure drops excessively or symptoms of syncope or shock develop, immediate consultation with medical personnel is required, and hyperkalemia and renal function should be monitored periodically. This drug may increase the blood pressure-lowering effects when used in conjunction with other antihypertensives; therefore, patients must inform their healthcare provider of all medications being taken. Also, caution is needed when used along with lithium, certain diuretics, and non-steroidal anti-inflammatory drugs due to increased risk of side effects. It is advisable not to take this drug within 24 hours before surgery and to be cautious of dizziness or fainting when driving or operating machinery. This drug is not recommended for children and adolescents under 18 years of age as its safety and efficacy have not been established in this population. In cases of overdose, symptoms such as low blood pressure, dizziness, and acute kidney failure may occur; hence immediate emergency treatment is required as this drug is not removed by dialysis, warranting careful observation and symptomatic treatment. This drug should be stored out of reach of children and should not be transferred to other containers.
Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, sepsis, anaphylactic reaction, angioedema (including fatal outcomes), angioedema, kidney disorders including acute kidney failure, shock, syncope, loss of consciousness, liver dysfunction, jaundice, anaphylactoid symptoms, laryngeal edema, interstitial pneumonia, rhabdomyolysis, paralysis, severe skin reactions, serious neurological symptoms, severe edema or urination
Upper respiratory infections (including pharyngitis and sinusitis), urinary tract infections, cystitis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, hyperkalemia, hypoglycemia, hyponatremia, depression, insomnia, anxiety, syncope, drowsiness, visual disturbances, dizziness, bradycardia, tachycardia, hypotension, orthostatic hypotension, dyspnea, cough, interstitial lung disease, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, taste disturbances, liver function
Not everyone experiences these, and they can vary from person to person.
This drug should be stored in a tightly closed container to prevent exposure to air or moisture. It is best kept at room temperature between 1 to 30 degrees Celsius.
White or almost white, biconvex, round tablets
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Pamgen Science Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.